Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccines, Combined”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00027833
What this trial is testing

Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Herbert Irving Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01367158
What this trial is testing

Safety, Tolerability and Immunogenicity of a Third Dose of One of Four Different Formulations of rMenB + MenACWY Combination Vaccine in Adolescents Who Previously Received the Same Study Vaccines

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 440
Large-scale testing (Phase 3)Study completedNCT01983540
What this trial is testing

Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination

Who this might be right for
DiphtheriaTetanusWhooping Cough+3 more
Sanofi Pasteur, a Sanofi Company 558
Very early researchStudy completedNCT00795457
What this trial is testing

Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas

Who this might be right for
AstrocytomaOligo-AstrocytomaGlioma
Ian F. Pollack, M.D. 13
Testing effectiveness (Phase 2)Looking for participantsNCT06675201
What this trial is testing

Neoantigen Vaccines in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)Neoantigen-loaded Dendritic Cell VaccineImmune Checkpoint Inhibitors (ICIs)
Sichuan University 165
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04433221
What this trial is testing

Combination Immunotherapy Targeting Sarcomas

Who this might be right for
SarcomaOsteoid SarcomaEwing Sarcoma
Shenzhen Geno-Immune Medical Institute 20
Post-approval studies (Phase 4)Study completedNCT00802867
What this trial is testing

Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Sanofi Pasteur, a Sanofi Company 989
Post-approval studies (Phase 4)Study completedNCT00125047
What this trial is testing

Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood

Who this might be right for
TyphoidParatyphoid Fever
International Vaccine Institute 27,231
Testing effectiveness (Phase 2)Study completedNCT02677155
What this trial is testing

Sequential Intranodal Immunotherapy (SIIT) Combined With Anti-PD1 (Pembrolizumab) in Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Oslo University Hospital 10
Large-scale testing (Phase 3)Study completedNCT02992925
What this trial is testing

Phase 3 Study of BK1310 in Healthy Infants

Who this might be right for
Immunization; Infection
Tanabe Pharma Corporation 370
Post-approval studies (Phase 4)Study completedNCT00289731
What this trial is testing

Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc

Who this might be right for
Hepatitis BHepatitis A
GlaxoSmithKline 596
Early research (Phase 1)UnknownNCT00532974
What this trial is testing

Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART)

Who this might be right for
HIV Infections
Epimmune 32
Post-approval studies (Phase 4)UnknownNCT04053010
What this trial is testing

Clinic Trial to Evaluate the Safety and Immunogenicity of Combined Immunization of sIPV and DTaP

Who this might be right for
Vaccination
China National Biotec Group Company Limited 702
Large-scale testing (Phase 3)WithdrawnNCT06482359
What this trial is testing

Lot Consistency Study of COVID-19 and Influenza Combination Vaccine

Who this might be right for
COVID-19Influenza
Novavax
Testing effectiveness (Phase 2)Study completedNCT00376779
What this trial is testing

Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age

Who this might be right for
Acellular PertussisTetanusDiphtheria+3 more
GlaxoSmithKline 450
Large-scale testing (Phase 3)Study completedNCT00343889
What this trial is testing

Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio Vaccine

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Sanofi Pasteur, a Sanofi Company 379
Post-approval studies (Phase 4)UnknownNCT05870618
What this trial is testing

Immunogenicity and Safety of DTaP or DT Vaccine in 6 Year Old Children

Who this might be right for
Vaccine Reaction
Zhejiang Provincial Center for Disease Control and Prevention 480
Large-scale testing (Phase 3)Study completedNCT00289770
What this trial is testing

Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults

Who this might be right for
Hepatitis BHepatitis A
GlaxoSmithKline 50
Large-scale testing (Phase 3)Ended earlyNCT00133224
What this trial is testing

Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Cell Genesys 408
Very early researchLooking for participantsNCT06497010
What this trial is testing

An Exploratory Study of Individualized Neo-antigen mRNA Cancer Vaccine InnoPCV in Advanced Solid Tumor Treatment

Who this might be right for
Advanced Solid Tumor
The Affiliated Hospital Of Guizhou Medical University 40
Next Page